These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9392933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)--a case report].
    Muraoka A, Asami M, Ueno H, Yoneda R, Ogura M, Oribe T, Suzuki K, Maeda M, Chinzei T, Yamashiro K.
    Rinsho Ketsueki; 1990 Nov; 31(11):1840-4. PubMed ID: 2287070
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V, Molica S, Capalbo S, Pogliani E, Battista C, Broccia G, Montillo M, Cuneo A, Leoni P, Specchia G, Castoldi G.
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
    Tumakov VA, Abdulkadyrov KM, Rugal' VI, Karpenkov MV, Ved' VV, Brodovskiĭ AF.
    Klin Med (Mosk); 1991 Jan 01; 69(1):94-7. PubMed ID: 2023411
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. B-Prolymphocytic leukemia: a case study.
    Roberts JC, Roberts GH.
    Clin Lab Sci; 2001 Jan 01; 14(4):233-7. PubMed ID: 11760820
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.